
Does lithium lower the risk of Alzheimer disease?
Checked
Posts say that lithium can prevent Alzheimer's disease or lower the risk of getting it.
It is not proven that lithium lowers the risk of Alzheimer disease. 2 new studies in people are running or will start soon, say the trial registers.
What studies show
As of , no study proves that lithium lowers the risk of Alzheimer disease. We found 122 published papers on lithium and Alzheimer disease. They were published between 2016 and 2026. 13 of them are studies in people. 7 of them followed or compared people without deciding who got it (observational studies). Such studies can show a link, but not that one thing causes the other. At least 96,850 people took part. 4 of them were fair tests in which chance decided who got it and who did not. 36 were studies in animals, and 8 were only in cells in the lab. 38 papers are reviews that sum up other studies. 1 paper was retracted. 2 research projects on lithium for Alzheimer disease are funded and still running.
Trials in people
One trial gave lithium or a dummy pill to 61 older adults with mild memory problems. They took it for 2 years and were checked for 2 more. The lithium group scored higher on a memory and thinking test (25.5 vs 18.3). Many people had died or could not be reached, so the picture is incomplete. Two other trials tested lithium for agitation in people who already had Alzheimer's, not for prevention. Lithium was not clearly better than a dummy pill there.
Other studies in people
A UK study followed 29,618 people aged 50 or over. Only 548 of them used lithium. A 2026 study compared 67,020 people with lithium and 67,020 without, all with mood disorders. Studies like these show a link, not cause and effect. A Texas study found fewer Alzheimer's deaths in counties with more lithium in tap water. That link weakened after adjusting for obesity, diabetes and lack of exercise.
Reviews
A 2026 review of 23 studies found about 37% lower dementia risk with lithium. For Alzheimer's alone, the result was just short of being solid. Another 2026 review calls the evidence promising but not conclusive.
In animals
A 2025 study found lower brain lithium in people with mild memory problems. In mice, cutting brain lithium by about half sped up Alzheimer's-like changes and memory loss. A form called lithium orotate prevented these changes in mice. Results in animals do not always hold in people.
In the lab
In cells from an Alzheimer's patient, lithium chloride improved cell survival.
What this means for you
Our verdict: Unproven.
The one small trial aimed at prevention points to some benefit, but many people were lost. Large studies suggest a lower risk, but they cannot prove cause and effect.
Do not decide anything about lithium because of one story or post. A study in people is not proof that it will lower your own risk. If you are thinking about lithium to lower your risk of Alzheimer disease, ask your doctor first.
This page explains what research has found so far. It is not medical advice. Talk to your doctor before you start, stop or change any treatment.
We searched 19 scientific databases for research from the last 10 years (since 18 Nov 2016).
Sources
- Association of Lithium Exposure With Alzheimer's Disease: A Propensity Score-Matched Cohort Study. Cureus 2026. Observational study in people. PubMed
- Lithium therapy and delayed progression of Alzheimer's disease and related dementias in patients with bipolar disorder and mild neurocognitive disorders. medRxiv 2026. Observational study in people. PubMed
- Lithium exposure and risk of dementia and Alzheimer's disease: A systematic review and meta-analysis. J Alzheimers Dis 2026. Review. PubMed
- Molecular mechanisms of lithium neuroprotection in Alzheimer's disease: A systematic comprehensive review. J Trace Elem Med Biol 2026. Review. PubMed
- The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia: A Narrative Review. JAMA Psychiatry 2026. Review. PubMed
- Is lithium orotate beneficial for treating Alzheimer's disease?. Zenodo (CERN European Organization for Nuclear Research) 2026. Review. Zenodo (CERN European Organization for Nuclear Research)
- Chronic Lithium Exposure Reshapes PI3K-mTOR-linked Proteostatic Networks in the Hippocampus of an Alzheimer's Disease Mouse Model. Mol Neurobiol 2026. In animals. PubMed
- Neuroprotective effects of lithium and caffeic acid co-loaded liposomes in diabetes-induced Alzheimer's disease: association with GSK-3β and β-catenin. Nanomedicine (Lond) 2026. In animals. PubMed
- Lithium chloride suppresses ferroptosis of induced pluripotent stem cells with ApoE4/E4 from a sporadic Alzheimer's disease patient. Neurotherapeutics 2026. In the lab. PubMed
- Lithium orotate: distinct compound or simply Li+ after administration?. Br J Psychiatry 2026. Other paper. PubMed
- LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response. 2026. Study in people. ClinicalTrials.gov
- Lithium deficiency and the onset of Alzheimer's disease. Nature 2025. In animals. PubMed
- Lithium Chloride Improves Electrophysiological and Memory Deficits in Rats with Streptozotocin-Induced Alzheimer's Disease. Curr Alzheimer Res 2025. In animals. PubMed
- Comparison of the effects of lithium orotate and lithium carbonate on locomotion and memory in a Drosophila melanogaster model of Alzheimer’s disease. bioRxiv (Cold Spring Harbor Laboratory) 2025. In animals. bioRxiv (Cold Spring Harbor Laboratory)
- Lithium Chloride Inhibits Iron Dysregulation and Ferroptosis in Induced Pluripotent Stem Cells with ApoE4/E4 from a sporadic Alzheimer's disease patient. bioRxiv 2025. In the lab. PubMed
- Imaging lithium in Alzheimer's disease. 2025. Study in people. ISRCTN
- Revisiting global cognitive and functional state 13 years after a clinical trial of lithium for mild cognitive impairment. Braz J Psychiatry 2023. Randomised trial. PubMed
- Effects of lithium on serum Brain-Derived Neurotrophic Factor in Alzheimer's patients with agitation. Int J Geriatr Psychiatry 2023. Randomised trial. PubMed
- Lithium Cholesterol Sulfate: A Novel and Potential Drug for Treating Alzheimer's Disease and Autism Spectrum Disorder. CNS Neurol Disord Drug Targets 2023. In the lab. PubMed
- Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial. Am J Geriatr Psychiatry 2022. Randomised trial. PubMed
- Association between lithium use and the incidence of dementia and its subtypes: A retrospective cohort study. PLoS Med 2022. Observational study in people. PubMed
- Preparation and Multitarget Anti-AD Activity Study of Chondroitin Sulfate Lithium in AD Mice Induced by Combination of D-Gal/AlCl3. Oxid Med Cell Longev 2022. Retracted. PubMedRetracted
- Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial. Br J Psychiatry 2019. Randomised trial. PubMed
- Examining the Relationship between Trace Lithium in Drinking Water and the Rising Rates of Age-Adjusted Alzheimer's Disease Mortality in Texas. J Alzheimers Dis 2018. Observational study in people. PubMed
- Association of Lithium in Drinking Water With the Incidence of Dementia. JAMA Psychiatry 2017. Observational study in people. PubMed
- Association Between Lithium Use and Risk of Alzheimer's Disease. J Clin Psychiatry 2017. Observational study in people. PubMed
Frontlight Community
Share what you saw, tried or were told about this claim, and read what others went through. Posts are not medical advice: ask your doctor about your own treatment.
Be the first to share your experience or your question about this claim
You need a Frontlight account with a verified e-mail address to comment.
